Literature DB >> 26059519

Identification of Actinobacillus pleuropneumoniae Genes Preferentially Expressed During Infection Using In Vivo-Induced Antigen Technology (IVIAT).

Fei Zhang1, Yangyi Zhang1, Xintian Wen1, Xiaobo Huang1, Yiping Wen1, Rui Wu1, Qigui Yan1, Yong Huang1, Xiaoping Ma1, Qin Zhao1, Sanjie Cao1.   

Abstract

Porcine pleuropneumonia is an infectious disease caused by Actinobacillus pleuropneumoniae. The identification of A. pleuropneumoniae genes, specially expressed in vivo, is a useful tool to reveal the mechanism of infection. IVIAT was used in this work to identify antigens expressed in vivo during A. pleuropneumoniae infection, using sera from individuals with chronic porcine pleuropneumonia. Sequencing of DNA inserts from positive clones showed 11 open reading frames with high homology to A. pleuropneumoniae genes. Based on sequence analysis, proteins encoded by these genes were involved in metabolism, replication, transcription regulation, and signal transduction. Moreover, three function-unknown proteins were also indentified in this work. Expression analysis using quantitative real-time PCR showed that most of the genes tested were up-regulated in vivo relative to their expression levels in vitro. IVI (in vivoinduced) genes that were amplified by PCR in different A. pleuropneumoniae strains showed that these genes could be detected in almost all of the strains. It is demonstrated that the identified IVI antigen may have important roles in the infection of A. pleuropneumoniae.

Entities:  

Keywords:  Actinobacillus pleuropneumoniae; Differential expression; In vivo-induced genes

Mesh:

Substances:

Year:  2015        PMID: 26059519     DOI: 10.4014/jmb.1504.04007

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  4 in total

1.  Immunoprotective Efficacy of Six In vivo-Induced Antigens against Actinobacillus pleuropneumoniae as Potential Vaccine Candidates in Murine Model.

Authors:  Fei Zhang; Sanjie Cao; Zhuang Zhu; Yusheng Yang; Xintian Wen; Yung-Fu Chang; Xiaobo Huang; Rui Wu; Yiping Wen; Qigui Yan; Yong Huang; Xiaoping Ma; Qin Zhao
Journal:  Front Microbiol       Date:  2016-10-21       Impact factor: 5.640

2.  Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.

Authors:  Fei Zhang; Qin Zhao; Keji Quan; Zhuang Zhu; Yusheng Yang; Xintian Wen; Yung-Fu Chang; Xiaobo Huang; Rui Wu; Yiping Wen; Qigui Yan; Yong Huang; Xiaoping Ma; Xinfeng Han; Sanjie Cao
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

3.  Effective Pro-Inflammatory Induced Activity of GALT, a Conserved Antigen in A. Pleuropneumoniae, Improves the Cytokines Secretion of Macrophage via p38, ERK1/2 and JNK MAPKs Signal Pathway.

Authors:  Fei Zhang; Qin Zhao; Jin Tian; Yung-Fu Chang; Xintian Wen; Xiaobo Huang; Rui Wu; Yiping Wen; Qigui Yan; Yong Huang; Xiaoping Ma; Xinfeng Han; Chang Miao; Sanjie Cao
Journal:  Front Cell Infect Microbiol       Date:  2018-09-25       Impact factor: 5.293

4.  Genome-wide screening of lipoproteins in Actinobacillus pleuropneumoniae identifies three antigens that confer protection against virulent challenge.

Authors:  Yurou Cao; Lulu Gao; Li Zhang; Lixiang Zhou; Jihong Yang; Lingfu Deng; Jin Zhao; Chao Qi; Jinlin Liu
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.